CIK 0000718937
- Large accelerated filer
STAAR SURGICAL CO
Sign in to watch- Ticker
- STAA
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Jan 2
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953797439
- Phone
- +1 626-303-7902
- Business address
- 1911 WALKER AVE, MONROVIA, CA, 91016
- Former names
- STAAR SURGICAL COMPANY
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | Foust Warren President and CEO | Option exercise | +7,331 | 93,887 | ||
| 2026-08-14 | Foust Warren President and CEO | Shares withheld for taxes | −3,730 | $26.18 | $98K | 97,617 |
| 2026-08-14 | Foust Warren President and CEO | Option exercise | +3,666 | 93,951 | ||
| 2026-08-14 | Foust Warren President and CEO | Shares withheld for taxes | −1,865 | $26.18 | $49K | 95,816 |
| 2026-08-14 | Foust Warren President and CEO | Grant or award · Restricted Stock Units | +22,493 | 22,493 | ||
| 2026-08-14 | Foust Warren President and CEO | Grant or award · Stock Option (right to buy) | +40,471 | 40,471 | ||
| 2026-08-14 | Foust Warren President and CEO | Grant or award · Stock Option (right to buy) | +37,962 | 37,962 | ||
| 2026-08-14 | Foust Warren President and CEO | Grant or award · Performance Stock Option (right to buy) | +131,830 | 131,830 | ||
| 2026-08-14 | Foust Warren President and CEO | Grant or award · Performance Stock Option (right to buy) | +123,659 | 123,659 | ||
| 2026-08-14 | Foust Warren President and CEO | Option exercise · Performance Stock Units | +7,331 | 93,887 | ||
| 2026-08-14 | Foust Warren President and CEO | Option exercise · Performance Stock Units | +3,666 | 97,553 | ||
| 2026-07-31 | Foust Warren President and CEO | Option exercise | +20,787 | 97,132 | ||
| 2026-07-31 | Foust Warren President and CEO | Shares withheld for taxes | −10,576 | $24.36 | $258K | 86,556 |
| 2026-07-31 | Foust Warren President and CEO | Option exercise · Restricted Stock Units | −20,787 | 0 | ||
| 2026-05-15 | Foust Warren Interim Co-CEO and Pres. & COO | Grant or award | +14,662 | 81,579 | ||
| 2026-05-15 | Foust Warren Interim Co-CEO and Pres. & COO | Shares withheld for taxes | −7,460 | $32.07 | $239K | 74,119 |
| 2026-05-15 | Foust Warren Interim Co-CEO and Pres. & COO | Grant or award | +7,331 | 81,450 | ||
| 2026-05-15 | Foust Warren Interim Co-CEO and Pres. & COO | Shares withheld for taxes | −3,730 | $32.07 | $120K | 77,720 |
| 2026-05-15 | Foust Warren Interim Co-CEO and Pres. & COO | Grant or award | +7,331 | 85,051 | ||
| 2026-05-15 | Foust Warren Interim Co-CEO and Pres. & COO | Shares withheld for taxes | −3,730 | $32.07 | $120K | 81,321 |
Page 1 of 3 · 44 trades